DUX4 and facioscapulohumeral muscular dystrophy: We report that DUX4 affects WNT/β-CATENIN signalling to cause deleterious effects in FSHD and that molecular antagonism between DUX4 and DUX4c moderates FSHD pathomechanisms through seven major findings.